MedTrace Logo

TELSYS - TELmisartan Effectiveness in Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 or Older

NCT02242877 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3320

Last updated 2014-09-17

No results posted yet for this study

Summary

The aim of this study is to compare the effect of treatment with telmisartan on patients in whom the systolic BP is approximately 12 weeks after starting treatment under control for the first time between patients with isolated systolic hypertension (ISH) at the beginning to patients with systolic/diastolic hypertension (SDH)

Conditions

Interventions

DRUG

Telmisartan

DRUG

Telmisartan combined with hydrochlorothiazide

Sponsors & Collaborators

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2006-10-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02242877 on ClinicalTrials.gov